跳转至内容
Merck

B75956

Sigma-Aldrich

4-溴苯硼酸

≥95.0%

别名:

4-溴苯基硼酸

登录查看公司和协议定价


About This Item

线性分子式:
BrC6H4B(OH)2
CAS号:
分子量:
200.83
Beilstein:
2936347
EC號碼:
MDL號碼:
分類程式碼代碼:
12352103
PubChem物質ID:
NACRES:
NA.22

品質等級

化驗

≥95.0%
95%

形狀

crystals

mp

284-288 °C (lit.)

SMILES 字串

OB(O)c1ccc(Br)cc1

InChI

1S/C6H6BBrO2/c8-6-3-1-5(2-4-6)7(9)10/h1-4,9-10H

InChI 密鑰

QBLFZIBJXUQVRF-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

應用

试剂用于
  • 钯催化 Suzuki-Miyaura 交叉偶联
  • 钯(II)催化的非对映选择性共轭加成
  • 钯催化烯丙基酯与芳基硼酸的立体选择性 Heck 型反应
  • 串联型Pd(II)催化的氧化Heck反应和分子内C-H酰胺化序列
  • 铜介导芳基硼酸与氟烷基碘的无连接有氧氟烷基化反应
  • Pd催化炔烃的碳钯化芳基环化炔烃或烯酮
  • 铜催化的交叉耦合

试剂用于制备
  • 具有潜在抗肿瘤活性的含没食子酸酯的 obovatol 类似物
  • 蛋白调节剂、酶抑制剂和激酶抑制剂

其他說明

含不定量的酸酐

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

標靶器官

Respiratory system

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

James A Jordan-Hore et al.
Organic letters, 14(10), 2508-2511 (2012-05-02)
Ligand-free cationic Pd(II) catalyst with NaNO3 as an additive is a highly active catalytic system for conjugate additions to sterically hindered γ-substituted cyclohexenones. More challenging γγ- and βγ-substrates also react well to produce products with quaternary centers in good dr.
Synthesis of obovatol derivatives and their preliminary evaluation as antitumor agents
Lee, M.-S.; et al.
Bull. Korean Chem. Soc., 28, 1601-1604 (2007)
Jingyi Ye et al.
International journal of nanomedicine, 14, 5623-5636 (2019-08-24)
The objective of this study was to compare the in vitro Fick's first law, in vitro lipolysis, and in vivo rat assays for oral absorption of Biopharmaceutical Classification Systems Class II (BCS II) drugs in self-nanoemulsifying drug delivery system (SNEDDS)
Tahlia R Meola et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 129, 145-153 (2018-06-02)
The synergistic effect of nanosizing and lipid-based drug delivery systems (LBDDS) was explored to enhance formulation drug loading levels and improve drug solubilisation in the gastrointestinal environment. A novel formulation combining drug nanocrystals and silica-lipid hybrid (SLH) microparticles as a
Chuan Xiao et al.
Bioorganic & medicinal chemistry, 19(23), 7100-7110 (2011-11-01)
A series of purine nucleoside analogues bearing an aryl and hetaryl group in position 6 were prepared and their biological activities were assessed by in vitro CDK1/Cyclin B1 and CDK2/Cyclin A2 kinase assay. From the synthesized chemicals, three Xylocydine derivatives

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门